Ventac Partners is a dedicated life science company builder and consulting firm with offices in the United States, Europe and China. We have a strong track record founding new innovative companies as well as in fund raising, deal making, executive management and corporate finance. All partners are “hands-on” life science entrepreneurs, former pharma executives and/or legal experts that work as a team to source exciting new technologies from universities and pharma. We then build a business team, secure funding with other investors and grow the company to an exit. Recent IPOs, where Ventac Partners is an early and long term shareholder, include Idogen (tolerogenic cell therapies) and RhoVac (cancer vaccines) on the Spotlight stock exchange in Sweden.
We are currently looking to increase our footprint in the USA including the Boston, San Diego and Miami areas.